nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CHRM3—ureter—vaginal cancer	0.19	0.19	CbGeAlD
Ziprasidone—CHRM5—epithelium—vaginal cancer	0.0292	0.0292	CbGeAlD
Ziprasidone—HTR1E—female gonad—vaginal cancer	0.0287	0.0287	CbGeAlD
Ziprasidone—H1F0—uterine cervix—vaginal cancer	0.0249	0.0249	CbGeAlD
Ziprasidone—DRD5—female reproductive system—vaginal cancer	0.0241	0.0241	CbGeAlD
Ziprasidone—H1F0—urethra—vaginal cancer	0.0229	0.0229	CbGeAlD
Ziprasidone—H1F0—endometrium—vaginal cancer	0.0225	0.0225	CbGeAlD
Ziprasidone—DRD5—female gonad—vaginal cancer	0.022	0.022	CbGeAlD
Ziprasidone—H1F0—mammalian vulva—vaginal cancer	0.0218	0.0218	CbGeAlD
Ziprasidone—H1F0—uterus—vaginal cancer	0.0208	0.0208	CbGeAlD
Ziprasidone—H1F0—female reproductive system—vaginal cancer	0.0187	0.0187	CbGeAlD
Ziprasidone—H1F0—female gonad—vaginal cancer	0.017	0.017	CbGeAlD
Ziprasidone—H1F0—vagina—vaginal cancer	0.0169	0.0169	CbGeAlD
Ziprasidone—HTR7—epithelium—vaginal cancer	0.0155	0.0155	CbGeAlD
Ziprasidone—ADRA1A—epithelium—vaginal cancer	0.015	0.015	CbGeAlD
Ziprasidone—HTR1B—female reproductive system—vaginal cancer	0.0149	0.0149	CbGeAlD
Ziprasidone—CHRM3—urethra—vaginal cancer	0.0149	0.0149	CbGeAlD
Ziprasidone—HTR1D—female reproductive system—vaginal cancer	0.0145	0.0145	CbGeAlD
Ziprasidone—KCNH2—uterine cervix—vaginal cancer	0.0143	0.0143	CbGeAlD
Ziprasidone—HTR2C—female reproductive system—vaginal cancer	0.0143	0.0143	CbGeAlD
Ziprasidone—ADRA2C—uterine cervix—vaginal cancer	0.0141	0.0141	CbGeAlD
Ziprasidone—SLC6A4—female reproductive system—vaginal cancer	0.0136	0.0136	CbGeAlD
Ziprasidone—CHRM1—female reproductive system—vaginal cancer	0.0135	0.0135	CbGeAlD
Ziprasidone—KCNH2—urethra—vaginal cancer	0.0132	0.0132	CbGeAlD
Ziprasidone—ADRA2C—urethra—vaginal cancer	0.013	0.013	CbGeAlD
Ziprasidone—KCNH2—endometrium—vaginal cancer	0.013	0.013	CbGeAlD
Ziprasidone—ADRA2C—endometrium—vaginal cancer	0.0128	0.0128	CbGeAlD
Ziprasidone—ADRA2C—mammalian vulva—vaginal cancer	0.0124	0.0124	CbGeAlD
Ziprasidone—CHRM3—female reproductive system—vaginal cancer	0.0121	0.0121	CbGeAlD
Ziprasidone—KCNH2—uterus—vaginal cancer	0.0119	0.0119	CbGeAlD
Ziprasidone—CYP3A5—uterine cervix—vaginal cancer	0.0118	0.0118	CbGeAlD
Ziprasidone—ADRA2C—uterus—vaginal cancer	0.0118	0.0118	CbGeAlD
Ziprasidone—HRH1—epithelium—vaginal cancer	0.0116	0.0116	CbGeAlD
Ziprasidone—HTR7—female reproductive system—vaginal cancer	0.0115	0.0115	CbGeAlD
Ziprasidone—HRH1—uterine cervix—vaginal cancer	0.0115	0.0115	CbGeAlD
Ziprasidone—ADRA2A—uterine cervix—vaginal cancer	0.0113	0.0113	CbGeAlD
Ziprasidone—CHRM3—female gonad—vaginal cancer	0.011	0.011	CbGeAlD
Ziprasidone—KCNH2—female reproductive system—vaginal cancer	0.0107	0.0107	CbGeAlD
Ziprasidone—HRH1—urethra—vaginal cancer	0.0106	0.0106	CbGeAlD
Ziprasidone—HRH1—endometrium—vaginal cancer	0.0104	0.0104	CbGeAlD
Ziprasidone—ADRA2A—urethra—vaginal cancer	0.0104	0.0104	CbGeAlD
Ziprasidone—ADRA2A—endometrium—vaginal cancer	0.0102	0.0102	CbGeAlD
Ziprasidone—HRH1—mammalian vulva—vaginal cancer	0.01	0.01	CbGeAlD
Ziprasidone—ADRA2A—mammalian vulva—vaginal cancer	0.00987	0.00987	CbGeAlD
Ziprasidone—KCNH2—female gonad—vaginal cancer	0.00977	0.00977	CbGeAlD
Ziprasidone—KCNH2—vagina—vaginal cancer	0.00971	0.00971	CbGeAlD
Ziprasidone—HTR2A—epithelium—vaginal cancer	0.00967	0.00967	CbGeAlD
Ziprasidone—ADRA2C—female gonad—vaginal cancer	0.00964	0.00964	CbGeAlD
Ziprasidone—ADRA2C—vagina—vaginal cancer	0.00958	0.00958	CbGeAlD
Ziprasidone—ADRA2A—uterus—vaginal cancer	0.0094	0.0094	CbGeAlD
Ziprasidone—HRH1—female reproductive system—vaginal cancer	0.0086	0.0086	CbGeAlD
Ziprasidone—ADRA2A—female reproductive system—vaginal cancer	0.00845	0.00845	CbGeAlD
Ziprasidone—CYP3A5—female gonad—vaginal cancer	0.00807	0.00807	CbGeAlD
Ziprasidone—CYP3A5—vagina—vaginal cancer	0.00802	0.00802	CbGeAlD
Ziprasidone—HRH1—female gonad—vaginal cancer	0.00783	0.00783	CbGeAlD
Ziprasidone—HRH1—vagina—vaginal cancer	0.00778	0.00778	CbGeAlD
Ziprasidone—ADRA2A—female gonad—vaginal cancer	0.00769	0.00769	CbGeAlD
Ziprasidone—ADRA2A—vagina—vaginal cancer	0.00764	0.00764	CbGeAlD
Ziprasidone—HTR2A—female reproductive system—vaginal cancer	0.00719	0.00719	CbGeAlD
Ziprasidone—CYP3A4—female reproductive system—vaginal cancer	0.00665	0.00665	CbGeAlD
Ziprasidone—CYP2D6—female reproductive system—vaginal cancer	0.00655	0.00655	CbGeAlD
Ziprasidone—HTR2A—vagina—vaginal cancer	0.0065	0.0065	CbGeAlD
Ziprasidone—CYP2D6—female gonad—vaginal cancer	0.00596	0.00596	CbGeAlD
